Non-Human Primate (NHP) Biomarker Profiling Services

Are you currently facing long drug development cycles, difficulty in biomarker discovery, or challenges in validating therapeutic efficacy? Accelerate Your Drug Discovery Process! Our NHP Biomarker Profiling Service helps you accelerate drug discovery, validate therapeutic targets, and streamline preclinical research by providing high-quality, reproducible biomarker data through advanced multilayer omics technologies and a state-of-the-art NHP resource platform. We offer an integrated solution to help you make informed decisions, faster.

Introduction of Our NHP Biomarker Profiling Service

The Non-Human Primate (NHP) Biomarker Profiling Service leverages the immense value of NHPs in preclinical research. Due to their close genetic, physiological, and immunological similarities to humans, NHPs are a critical bridge between in vitro studies and clinical trials. This makes them the ideal model for investigating disease mechanisms, testing drug safety, and validating therapeutic efficacy. At Creative Biolabs, our service is designed to provide comprehensive, high-resolution molecular insights that are directly translatable to human health, significantly de-risking your development pipeline.

What Our Service Is

Our comprehensive service suite provides deep, multi-faceted insights into biological processes. We employ a variety of advanced technologies to analyze a wide range of biomarkers from NHP samples.

• Cytokine/Chemokine Multiplex: These platforms allow for the simultaneous quantification of multiple cytokines and chemokines from a single, small-volume sample. This is essential for understanding inflammatory responses, immune system modulation, and disease progression.
  • Application Scenario 1: Evaluating the immunomodulatory effects of a novel therapeutic in an NHP disease model.
  • Application Scenario 2: Monitoring the systemic inflammatory profile in response to a viral challenge or vaccine administration.
• Receptor Occupancy (Flow Cytometry): Flow cytometry enables precise measurement of how a drug binds to its target receptors on cell surfaces. This is a critical pharmacodynamic biomarker for determining optimal dosing, understanding drug-target engagement, and establishing efficacy.
  • Application Scenario 1: Determining the optimal dose of a monoclonal antibody by measuring its binding to target cells over time.
  • Application Scenario 2: Assessing drug-target engagement in different tissue compartments to inform clinical trial design.
• Tissue IHC/IF & In Situ Hybridization: These techniques allow for the localization and quantification of proteins and nucleic acids directly within tissue sections. They provide essential context for understanding cellular function and pathological changes.
  • Application Scenario 1: Localizing a drug's target within specific cell types in a diseased tissue to confirm its mechanism of action.
  • Application Scenario 2: Analyzing RNA biomarker expression in tumors to predict response to a novel oncology drug.

Why Choose Us?

We understand the challenges inherent in preclinical research. Long turnaround times, lack of standardized protocols, and data variability can delay your project and increase costs. Creative Biolabs addresses these pain points directly by providing:

• Actionable Data: We don't just deliver numbers; we provide actionable insights. Our multilayer omics approach helps you connect molecular changes to physiological outcomes, leading to clearer, more confident decisions.
• Expertise and Experience: Our team of specialists has over 20 years of experience in biomarker profiling, ensuring your project is handled with the highest level of scientific rigor.
• Reduced Risk: By providing a comprehensive and predictive picture of drug performance in NHPs, we help you identify potential issues early in the pipeline, saving you significant time and resources.

Fig.1 Extensive inventory of RNA genes and proteins in rhesus monkey blood.¹

Key Benefits of Our Service

Creative Biolabs' NHP Biomarker Profiling Service is designed to empower your research with unparalleled speed, depth, and reliability. We recognize that every project is unique, and our services are built with flexibility and precision in mind.

• Superior NHP Resources: We partner with leading, ethically-vetted NHP facilities, ensuring access to a diverse and well-characterized cohort of animals. This allows for study designs that are scientifically robust and produce highly translatable data.
• Unmatched Response Speed: We are committed to an industry-leading turnaround time. For a standard, multi-omics biomarker panel, our typical turnaround time from sample receipt to comprehensive report is within 5-10 business days. This rapid delivery allows for real-time decision-making in fast-paced preclinical studies.
• Comprehensive Customization: Our platform is not a one-size-fits-all solution. We work closely with you to design a custom biomarker panel that is perfectly tailored to your project's specific needs, whether you require a small, focused panel or a broad, multi-omics approach.
• Reporting Depth and Clarity: Our deliverables go beyond raw data. We provide in-depth, annotated reports with clear visualizations that highlight key findings and their biological significance.

How Creative Biolabs' NHP Services Can Assist Your Project?

Our service is designed as a clear, step-by-step workflow to ensure transparency and efficiency, from the initial consultation to the final report. We provide a collaborative partnership, not just a service, to help you navigate complex research challenges.

Key Deliverables

Upon completion of your project, you will receive a comprehensive package of deliverables, meticulously prepared for clarity and usability:

• A detailed laboratory report summarizing all methods and key findings.
• Raw data files from all assays.
• Annotated figures, graphs, and tables for easy visualization of results.
• A summary of our bioinformatic analysis, including statistical outcomes and pathway analysis.
• Model annotations and predictive biomarker signatures where applicable.

Capabilities & Partnerships

Service-Specific Data

• Annual Sample Size: Over 50,000 samples analyzed per year.
• Turnaround Time (TAT): Typical turnaround of 2 weeks for bioanalytical results.
• Study Pass Rate: 99%+ success rate in meeting study endpoints.

Our Valued Partners

Frequently Asked Questions

Contact Us

Creative Biolabs' NHP Biomarker Profiling Service provides a comprehensive, high-resolution solution for advancing your preclinical research. By leveraging the genetic and physiological advantages of NHPs and combining them with our state-of-the-art multilayer omics platform, we deliver actionable insights that can accelerate your drug discovery process. Our commitment to speed, customization, and reporting depth ensures you receive the data you need to make confident decisions, faster. Reach out to one of our specialists to learn how our tailored solutions can address your specific research needs and help you achieve your project goals.